Sirtuins and Aging

被引：0
|
作者：
Pukhalskaia A.E. [1 ]
Kvetnoy I.M. [2 ,3 ]
Linkova N.S. [1 ,4 ,5 ]
Diatlova A.S. [1 ]
Gutop E.O. [1 ]
Kozlov K.L. [1 ]
Paltsev M.A. [6 ]
机构：
[1] Department of Biogerontology, St. Petersburg Institute of Bioregulation and Gerontology, St. Petersburg
[2] Department of Pathology, St. Petersburg State University, St. Petersburg
[3] Center for Molecular Biomedicine, St. Petersburg Research Institute of Phthysiopulmonology, St. Petersburg
[4] Department of Therapy, Geriatrics, and Antiaging Medicine, Academy of Postgraduate Education, Moscow
[5] Department of Biomedical Sciences, Belgorod National Research State University, St. Petersburg
[6] Center for Immunology and Molecular Biomedicine, Lomonosov Moscow State University, Moscow
来源：
Neuroscience and Behavioral Physiology | 2022年 / 52卷 / 9期
关键词：
age-associated diseases; cellular aging; geroprotection; sirtuins;
D O I：
10.1007/s11055-023-01379-8
中图分类号：
学科分类号：
摘要：
The sirtuin family of proteins (SIRT proteins) are involved in DNA repair, chromatin remodeling, epigenetic regulation of the expression of metabolism genes, the antioxidant system, apoptosis, immuno- and neurogenesis, etc. The aim of this review is to analyze the geroprotective properties of sirtuins in normal and age-associated pathologies. SIRT1, 2, 3, 4, and 6 contribute to increases in life expectancy. SIRT1, 2, 6, and 7 slow cellular aging and maintain the stem cell pool. Sirtuins are potential targets for the treatment of neurodegenerative, oncological, and cardiovascular diseases, metabolic syndrome, and diabetes mellitus. All these diseases are in most cases characteristic of elderly and old people, so the geroprotective effects of sirtuins, realized at the molecular and cellular levels, may play an important role in the treatment of these conditions. © 2023, Springer Nature Switzerland AG.
引用
收藏
页码：1482 / 1490
页数：8
相关论文
共 50 条
  • [21] Sirtuins and Accelerated Aging in Scleroderma
    Anne E. Wyman
    Sergei P. Atamas
    Current Rheumatology Reports, 2018, 20
  • [22] Sirtuins as regulators of mammalian aging
    Naiman, Shoshana
    Kanfi, Yariv
    Cohen, Haim Y.
    AGING-US, 2012, 4 (08): : 521 - 522
  • [23] Sirtuins, aging, and cardiovascular risks
    Gaia Favero
    Lorenzo Franceschetti
    Luigi Fabrizio Rodella
    Rita Rezzani
    AGE, 2015, 37
  • [24] A therapeutic role for sirtuins in diseases of aging?
    Westphal, C. H.
    Dipp, M. A.
    Guarente, L.
    TRENDS IN BIOCHEMICAL SCIENCES, 2007, 32 (12) : 555 - 560
  • [25] Sirtuins, Cell Senescence, and Vascular Aging
    Kida, Yujiro
    Goligorsky, Michael S.
    CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (05) : 634 - 641
  • [26] Sirtuins, nicotinamide and aging: A critical review
    Adams, James David, Jr.
    Klaidman, Lori K.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2007, 4 (01) : 44 - 48
  • [27] Sirtuins in Brain Aging and Neurological Disorders
    Qadir, Muhammad Imran
    Anwar, Sidra
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2017, 27 (04): : 321 - 329
  • [28] Sirtuins at the crossroads of stemness, aging, and cancer
    O'Callaghan, Carol
    Vassilopoulos, Athanassios
    AGING CELL, 2017, 16 (06): : 1208 - 1218
  • [29] NAD+ and sirtuins in aging and disease
    Imai, Shin-ichiro
    Guarente, Leonard
    TRENDS IN CELL BIOLOGY, 2014, 24 (08) : 464 - 471
  • [30] Sirtuins: Common Targets in Aging and in Neurodegeneration
    de Oliveira, Rita Machado
    Pais, Teresa F.
    Outeiro, Tiago Fleming
    CURRENT DRUG TARGETS, 2010, 11 (10) : 1270 - 1280
12345